A discussion and Q&A regarding polycythemia vera ~ SAVE THE DATE ~ 3/25/21
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
Science for a Better Life ~ Colorectal Cancer - Disease Overview ~ 4/28/21
Lunchtime Webinar:Elevate Care in Advanced Prostate Cancer
Chronic Lymphocytic Leukemia in Rural America - 1.0 CNE Program
Granulocyte Colony Stimulating Factor Biosimilars: An Update for Frontline Oncology Practitioners
TAGRISSO in the Treatment of Resectable NSCLC with EGFR Exon 19 Deletions or Exon 21 L858R Mutations
A program on an FDA-approved treatment option metastatic Urothelial Carcinoma ~ PADCEV
Patient Access Services and Reimbursement Overview
Impact of Long-Term Echelon-1 Data in Stage III/IV CHL
TAZVERIK (tazemetostat) ~ Relapsed or Refractory Follicular Lymphoma
TAZVERIK ~ Now Approved ~ Virtual Talk Thursday, 12/10/20 @ 5:00PM
A Treatment Option for the Management of Patients With First-Line NSCLC & Metastatic Melanoma
BONS Members ONLY ~ New Evidence in First-Line AML & Exploring Outcomes
Combining the HER2+ Breast Cancer Antibodies You Know in One Fixed-Dose Subcutaneous Injection ~ NEW
Introducing BLENREP (belantamab mafodotin-blmf) ~
Enriching Communication Skills for Oncofertility ~ All Virtual Training Course ~ 17.75 CMEs!
IMBRUVICA (IBRUTINIB) With A Focus on Walsenstrom's Macroglobulinemia (WM) ~ TOMORROW @ 12:15pm
A Treatment Option for the Management of Certain Patients With First-Line Non-Small Cell Lung Cancer